{
    "organizations": [],
    "uuid": "467de1d3a638a9666f465d80b8b48d69e7553349",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-hayat-pharmaceutical-industries-fy/brief-hayat-pharmaceutical-industries-fy-profit-rises-idUSFWN1Q50NE",
    "ord_in_thread": 0,
    "title": "BRIEF-Hayat Pharmaceutical Industries FY Profit Rises",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 15 (Reuters) - HAYAT PHARMACEUTICAL INDUSTRIES COMPANY :\n* FY NET PROFIT ATTRIBUTABLE TO SHAREHOLDERS 2.5 MILLION DINARS VERSUS 2.3‍​ MILLION DINARS YEAR AGO\n* FY NET OPERATING REVENUE 12.7 ‍​MILLION DINARS VERSUS 10.5 ‍​MILLION DINARS YEAR AGO Source:( bit.ly/2CmEAnU ) Further company coverage:\n ",
    "published": "2018-02-15T18:28:00.000+02:00",
    "crawled": "2018-02-16T16:55:37.014+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "hayat",
        "pharmaceutical",
        "industry",
        "company",
        "fy",
        "net",
        "profit",
        "attributable",
        "shareholder",
        "million",
        "dinar",
        "versus",
        "million",
        "dinar",
        "year",
        "ago",
        "fy",
        "net",
        "operating",
        "revenue",
        "dinar",
        "versus",
        "dinar",
        "year",
        "ago",
        "source",
        "company",
        "coverage"
    ]
}